Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.
Zheng LiuJennifer H MartinWinston LiauwSue-Anne McLachlanEmma LinkAnetta MateraMichael ThompsonMichael JeffordRod J HicksCarleen CullinaneAthena HatzimihalisIan CampbellSimone CrowleyPhillip J BealeChristos S KarapetisTimothy PriceMathew E BurgeMichael MichaelPublished in: European journal of clinical pharmacology (2021)
The identified UGT1A3_c.31 T > C and ABCB1_c.3435C > T variants, from wild type to homozygous, were included in the final model for SN38 clearance.